Transcatheter tricuspid valve-in-valve implantation for degenerative surgical bio-prosthesis using SAPIEN 3: A case series.
Mann ChandavimolTawai NgernsritrakulKrissada MeemookSirin ApinyasawatTarinee TangcharoenPavit PienvichitPiya SamankatiwatSarana BoonbaichaiyapruckPublished in: Clinical case reports (2021)
We evaluated early outcomes of transcatheter valve-in-valve (ViV) implantation in patients with degenerated bio-prosthesis in tricuspid position. Total of 5 patients were included in our case series. Baseline native tricuspid valve etiology were highly varied ranging from chest wall trauma, Ebstein anomaly, rheumatic heart disease, infective endocarditis and complex congenital heart disease. These differences also made patient comorbidities highly varied. Procedure details were also varied due to different clinical and technical challenges. All cases underwent successful Tricuspid VIV implantation with satisfactory hemodynamics results. All patients experienced improved clinical symptoms at follow up.
Keyphrases
- aortic valve
- mitral valve
- aortic stenosis
- ejection fraction
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- congenital heart disease
- end stage renal disease
- newly diagnosed
- left ventricular
- prognostic factors
- heart failure
- rheumatoid arthritis
- type diabetes
- physical activity
- case report
- patient reported outcomes
- insulin resistance
- skeletal muscle
- atrial fibrillation